Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal ...

Research confirms the Lumipulse serum p-tau217 assay's effectiveness in diagnosing Alzheimer's, paving the way for accessible ...

Region’s first Center for Advanced Neuro Biochemical Diagnostics to open in Abu Dhabi ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread ...

The interaction between the brain and the vascular system could hold the key to lowering disease risk. According to the ...

A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers for dementia are expressed in the blood, according to a new study.

Ellen’s experience highlights the growing promise of blood-based testing for Alzheimer’s. By identifying disease-specific biomarkers in the bloodstream, these tests offer a minimally invasive ...

The study supports prior research that found the same thing.

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...